Andrew Aswani: How NETs Contribute to Disease and Why They Matter
Andrew Aswani, Co-Founder, Chief Medical Officer at Santersus AG shared a post on LinkedIn about a recent article by Michal Santocki and Elzbieta Kolaczkowska, published in Cells:
”The growing body of research on neutrophil extracellular traps (NETs) continues to reshape our understanding of inflammation, immunity, and thrombosis.
This 2020 foundational MDPI review on immune‑complex-induced NETosis highlights that NETs are not just byproducts of inflammation-they are active drivers of vascular injury, coagulation, and organ dysfunction.
When NETs accumulate unchecked, they create a cascade of endothelial damage, platelet activation, and immune dysregulation that underpins some of the most severe conditions we face-sepsis, autoimmune disease, cancer, and cardiovascular complications.
At Santersus AG, we’re working to help clinicians intervene at this root cause. Our NucleoCapture platform is designed to selectively remove NETs from circulation, offering a targeted, extracorporeal approach that avoids the systemic side effects of many pharmacologic therapies. As the scientific community continues to validate the central role of NETs in immune‑driven thrombosis, the need for NET‑focused interventions becomes even more urgent.
This research strengthens the case for a new therapeutic paradigm-one that doesn’t just modulate inflammation, but directly removes the molecular drivers of immune‑mediated injury.”
Title: On Neutrophil Extracellular Trap (NET) Removal: What We Know Thus Far and Why So Little
Authors: Michal Santocki, Elzbieta Kolaczkowska
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 2, 2026, 10:35Dawn Carter: What Does an Acute Stroke Diagnosis Tell Us, If It Never Shows Up in Hospital Data?
-
Jun 2, 2026, 10:19Wolfgang Miesbach: Attitudes Towards Gene Therapy for Severe Haemophilia in Germany
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab